Encorafenib plus Binimetinib in patients with locally advanced, unresectable or metastatic BRAF V600 mutated melanoma: an ongoing multi-centric, multi-national, prospective, longitudinal, non-interventional study - BERING Melanoma
- Erika Richtig (Speaker)
- D Schadendorf (Author)
- C Loquai (Author)
- S Grabbe (Author)
- A Forschner (Author)
- R Gutzmer (Author)
- S Haferkamp (Author)
- J Utikal (Author)
- J Hassel (Author)
- F Meier (Author)
- D Debus (Author)
- M Fluck (Author)
- D Göppner (Author)
- H Kehrer (Author)
- R Dummer (Author)
- R Von Moos (Author)
- J Thompson (Author)
- L Milde (Author)
- O Michielin (Author)
- C Höller (Author)
Activity: Talk, presentation or poster › Poster